To catch colon cancer early, when it’s easier to treat and less
lethal, physicians typically recommend that adults aged 50 to 75 get
screened every 10 years with a colonoscopy or annually with fecal
tests. Nationwide, only about 67 percent of adults in this age range
were current with screening, the study found.
At the state level, screening rates ranged from a low of 59 percent
in Wyoming to a high of 75 percent in Massachusetts.
Researchers found even greater variability within some states.
Screening rates were lowest in one county in Alaska, at just 40
percent, and highest in one county in Florida, at 80 percent.
The widest gap among counties was in South Dakota, with a
29-percentage point difference between the counties with the lowest
and highest screening rates; the smallest gap was in Connecticut,
with about 4 percentage points separating the counties with the
highest and lowest screening rates.
“We anticipated variations by county in colorectal cancer screening
within the states because of different educational and income levels
and geographical inequalities, but we were still struck by
differences of more than 20 percentage points between counties in
some states,” said lead study author Zahava Berkowitz, of the
National Center for Chronic Disease Prevention and Health Promotion,
at the U.S. Centers for Disease Control and Prevention in Atlanta.
“Although most providers recommend colonoscopy, some people refuse
to undergo the preparation for the procedure and/or are afraid of an
invasive procedure,” Berkowitz said by email. “Therefore, it is
important that multiple screening options are offered to match
patients’ preferences.”
The most common screening method is a colonoscopy exam that snakes a
tiny camera through the rectum to view the colon to search for
abnormal tissue growth. Patients may need to use laxatives or an
enema to empty the bowels before the exam, and sedation is usually
required during the procedures.
An alternative is fecal occult blood testing (FOBT), which looks for
blood - a possible sign of cancer - in stool samples. Another option
involves doing FOBT every three years along with a sigmoidoscopy
exam of just the lower colon every five years.
[to top of second column] |
The U.S. Preventive Services Task Force, a government-backed
independent panel that assesses the evidence for medical procedures,
recommends using any of these methods starting at age 50 for adults
who don’t have inflammatory bowel disease or a family history of
colon cancer. People with those extra risk factors or other specific
conditions may need earlier or more intensive screening.
For the current study, researchers modeled county level screening
rates by using CDC survey data for 251,360 adults aged 50 to 75 and
looking at U.S. population estimates for 3,142 counties nationwide.
Screening varied by ethnicity, with about 69 percent of white adults
current on recommended screenings, compared with 57 percent of
Hispanics, the study found.
One limitation of the study is that researchers relied on survey
participants to accurately recall and report their screening exams,
and inaccurate responses might throw off the estimated screening
rates, researchers note in Cancer, Epidemiology, Biomarkers and
Prevention.
The study also doesn’t offer insight into why so many people are not
current with their recommended screenings, and there are many
factors that can contribute to this, said Electra Paskett, a cancer
researcher at Ohio State University in Columbus who wasn’t involved
in the study.
Screening rates tend to be lowest in places that don’t have polices
to cover these tests for everyone or don’t have providers in the
community who can do the tests, Paskett said by email. Doctors also
might not recommend screening, or people might not want it or want
to travel too far to get it.
“All of these act and interact in different ways to keep people from
screening,” Paskett added. “It matters because colorectal cancer is
totally preventable as is death from colorectal cancer if people get
screened regularly.”
SOURCE: https://bit.ly/2GkLQn0 Cancer, Epidemiology, Biomarkers and
Prevention, online March 1, 2018.
[© 2018 Thomson Reuters. All rights
reserved.] Copyright 2018 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content. |